BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17089089)

  • 1. Long-term outcome of ten children with opsoclonus-myoclonus syndrome.
    Klein A; Schmitt B; Boltshauser E
    Eur J Pediatr; 2007 Apr; 166(4):359-63. PubMed ID: 17089089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up.
    Catsman-Berrevoets CE; Aarsen FK; van Hemsbergen ML; van Noesel MM; Hakvoort-Cammel FG; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2009 Dec; 53(6):1048-53. PubMed ID: 19672966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
    Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
    Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae.
    Mitchell WG; Davalos-Gonzalez Y; Brumm VL; Aller SK; Burger E; Turkel SB; Borchert MS; Hollar S; Padilla S
    Pediatrics; 2002 Jan; 109(1):86-98. PubMed ID: 11773546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.
    Mitchell WG; Brumm VL; Azen CG; Patterson KE; Aller SK; Rodriguez J
    Pediatrics; 2005 Oct; 116(4):901-7. PubMed ID: 16199699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.
    Bataller L; Graus F; Saiz A; Vilchez JJ;
    Brain; 2001 Feb; 124(Pt 2):437-43. PubMed ID: 11157570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
    Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
    Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mood and behavioral dysfunction with opsoclonus-myoclonus ataxia.
    Turkel SB; Brumm VL; Mitchell WG; Tavare CJ
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):239-41. PubMed ID: 16720803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome.
    De Grandis E; Parodi S; Conte M; Angelini P; Battaglia F; Gandolfo C; Pessagno A; Pistoia V; Mitchell WG; Pike M; Haupt R; Veneselli E
    Neuropediatrics; 2009 Jun; 40(3):103-11. PubMed ID: 20020394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
    Blaes F; Dharmalingam B
    Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.
    Tate ED; Allison TJ; Pranzatelli MR; Verhulst SJ
    J Pediatr Oncol Nurs; 2005; 22(1):8-19. PubMed ID: 15574722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Opsoclonus myoclonus ataxia syndrome in Israel].
    Blumkin L; Lerman-Sagie T
    Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood opsoclonus-myoclonus syndrome: A case series from Tunisia.
    Ben Achour N; Mrabet S; Rebai I; Abid I; Benrhouma H; Klaa H; Rouissi A; Kraoua I; Ben Youssef Turki I
    Brain Dev; 2017 Oct; 39(9):751-755. PubMed ID: 28549713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paraneoplastic neurological syndrome in 12 children].
    Xiao J; Liu LY; Wu Y; Han TL; Wang X
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):598-600. PubMed ID: 23158737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS).
    Mitchell WG; Wooten AA; O'Neil SH; Rodriguez JG; Cruz RE; Wittern R
    J Child Neurol; 2015 Jul; 30(8):976-82. PubMed ID: 25342308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.
    Koh PS; Raffensperger JG; Berry S; Larsen MB; Johnstone HS; Chou P; Luck SR; Hammer M; Cohn SL
    J Pediatr; 1994 Nov; 125(5 Pt 1):712-6. PubMed ID: 7525913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsoclonus-ataxia due to childhood neural crest tumors: a chronic neurologic syndrome.
    Mitchell WG; Snodgrass SR
    J Child Neurol; 1990 Apr; 5(2):153-8. PubMed ID: 2345282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
    Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
    Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
    Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome.
    Rostásy K; Wilken B; Baumann M; Müller-Deile K; Bieber I; Gärtner J; Möller P; Angelini P; Hero B
    Neuropediatrics; 2006 Oct; 37(5):291-5. PubMed ID: 17236108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.